Last 30 days
Market attention
SAO · Brazil
REGN34 Regeneron Pharmaceuticals, Inc.
Current rank—Attention 0/100
Steady
Verified crowd view
What is your view on REGN34?
Choose once. You can change your view later. Automated and suspicious votes are not included.
BuildingThe result appears after enough verified votes.